Combinatory effects of gemcitabine and inhibitors targeting PI3K-Akt-mTOR pathway in human pancreatic and breast cancer cells.
datasetposted on 09.05.2012, 00:31 by Junmei Hou, Liewei Wang
The values represent the average of three independent experiments.b
IC50 values between combination treatment vs. Gem along were analyzed statistically by performing t tests.
Abbreviations: Gem, gemcitabine; TCN, tricirbine; Rap, rapamycin.